Project Grant HT94252310507
Award Date
6/15/23
Completion Date
6/14/26
Dollars Obligated
$763K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
New York University School of Medicine was awarded a $911,777 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into Mitochondrial Dynamics as a Therapy Target in Myelodysplastic Syndromes. Through September 2025, NYU School of Medicine researchers will investigate medical solutions for blood cancers like MDS by exploring mitochondrial functions and their potential as...
The Department of the Army Medical Command awarded New York University School of Medicine a $1,186,500 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2024 to understand the transition from nevi to melanoma occurring within the skin epidermis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $325,947 Project Grant to New York University (NYU) School of Medicine on September 15, 2024. The grant supports a 3-year research project titled "Genomic and Molecular Imprints of Carcinogenic Benzene Exposure." This funding enables NYU's research team to investigate the genomic and molecular impacts of benzene exposure, with the goal of advancing scientific...
The Defense Health Agency awarded a $1,694,245 Project Grant to New York University (NYU) School of Medicine, a private non-profit research institution and medical school, to develop innovative therapeutics against pressure ulcer-associated bacteria. The 4-year grant, which runs from August 2023 to August 2027, is funded under the Military Medical Research and Development program (CFDA 12.420). Through this award, NYU School of Medicine will conduct research to identify and advance new...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $680,757 project grant to New York University School of Medicine to conduct research titled "Targeting RAGE After Particulate Matter Exposure: Metabolic Dysregulation and Disease Mitigation." The grant, effective July 1, 2025 through June 30, 2028, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader...
The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...
The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
This $2,660,756 federal Project Grant award from the Department of Defense's Defense Health Agency supports research on "GENOMIC AND IMMUNOMIC MECHANISMS OF RESISTANCE DURING DARATUMUMAB POST STEM CELL TRANSPLANTATION IN PATIENTS WITH POOR-RISK T CELL LYMPHOBLASTIC LYMPHOMA LEUKEMIA". It is funded under the Military Medical Research and Development program (CFDA 12.420), which focuses on biomedical research to address health conditions affecting service members and veterans. The...
This Project Grant from the Department of the Army Medical Command provides $663,465 to New York University School of Medicine for research titled "Early Determinants of Melanoma Metastasis." The award period is from July 15, 2021 through July 14, 2024. The funding supports the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research. Specifically, the grant will fund New York...
The University of Rochester received a $812,602 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "IMAGING CANCER MICROENVIRONMENT HOT SPOTS INVOLVED IN PROGRESSION OF MYELODYSPLASTIC SYNDROMES." The research, which will take place from May 2024 to May 2027, aims to improve understanding of the cancer microenvironment and its role in the progression of myelodysplastic syndromes, a group of...